Literature DB >> 28004063

D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Neil A Zakai1, Leslie A McClure, Suzanne E Judd, Brett Kissela, George Howard, Monika Safford, Mary Cushman.   

Abstract

D-dimer, a biomarker of coagulation, is higher in blacks than in whites and has been associated with stroke and coronary heart disease (CHD). It was our objective to assess the association of higher D-dimer with stroke and CHD in blacks and whites. REGARDS recruited 30,239 black and white participants across the contiguous US and measured baseline D-dimer in stroke (n=646) and CHD (n=654) cases and a cohort random sample (n=1,104). Cox models adjusting for cardiovascular risk factors determined the hazard ratio (HR) for increasing D-dimer for cardiovascular disease with bootstrapping to assess the difference in HR for CHD versus stroke by race. D-dimer was higher with increasing age, female sex, diabetes, hypertension, pre-baseline cardiovascular disease and higher C-reactive protein (CRP). Accounting for cardiovascular risk factors, each doubling of D-dimer was associated with increased stroke (hazard ratio [HR] 1.15; 95 % confidence interval [CI] 1.01, 1.31) and CHD (HR 1.27; 95 % CI 1.11, 1.45) risk. The difference in the HR between CHD and stroke was 0.20 (95 % CI >0.00, 0.58) for blacks and 0.02 (95 % CI -0.30, 0.27) for whites. CRP mediated 22 % (95 % CI 5 %, 41 %) of the association between D-dimer and CHD and none of the association with stroke. Higher D-dimer increased the risk of stroke and CHD independent of cardiovascular risk factors and CRP, with perhaps a stronger association for CHD versus stroke in blacks than whites. These findings highlight potential different pathophysiology of vascular disease by disease site and race suggesting potential further studies targeting haemostasis in primary prevention of vascular disease.

Entities:  

Keywords:  Continental population groups; D-dimer; coronary disease; epidemiology stroke

Mesh:

Substances:

Year:  2016        PMID: 28004063      PMCID: PMC5824689          DOI: 10.1160/TH16-07-0519

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  28 in total

1.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

3.  N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.

Authors:  Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

4.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

5.  Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.

Authors:  P K MacCallum; P J Brennan; T W Meade
Journal:  Arch Intern Med       Date:  2000-09-11

6.  Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  Sarah R Gillett; Rebekah H Boyle; Neil A Zakai; Leslie A McClure; Nancy S Jenny; Mary Cushman
Journal:  Clin Biochem       Date:  2014-08-14       Impact factor: 3.281

7.  Are hemostatic factors responsible for the paradoxical risk factors for coronary heart disease and stroke?

Authors:  M Gliksman; A Wilson
Journal:  Stroke       Date:  1992-04       Impact factor: 7.914

8.  Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study.

Authors:  P L Lutsey; M Cushman; L M Steffen; D Green; R G Barr; D Herrington; P Ouyang; A R Folsom
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

9.  Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.

Authors:  Margaret May; Debbie A Lawlor; Rita Patel; Ann Rumley; Gordon Lowe; Shah Ebrahim
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-10

10.  Case-cohort design in practice - experiences from the MORGAM Project.

Authors:  Sangita Kulathinal; Juha Karvanen; Olli Saarela; Kari Kuulasmaa
Journal:  Epidemiol Perspect Innov       Date:  2007-12-04
View more
  12 in total

Review 1.  Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.

Authors:  Debora Kamin Mukaz; Neil A Zakai; Salvador Cruz-Flores; Louise D McCullough; Mary Cushman
Journal:  Stroke       Date:  2020-10-26       Impact factor: 7.914

Review 2.  Issues for the management of people with diabetes and COVID-19 in ICU.

Authors:  Antonio Ceriello; Eberhard Standl; Doina Catrinoiu; Baruch Itzhak; Nebojsa M Lalic; Dario Rahelic; Oliver Schnell; Jan Škrha; Paul Valensi
Journal:  Cardiovasc Diabetol       Date:  2020-07-20       Impact factor: 9.951

3.  Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.

Authors:  Navin Suthahar; Emily S Lau; Michael J Blaha; Samantha M Paniagua; Martin G Larson; Bruce M Psaty; Emelia J Benjamin; Matthew A Allison; Traci M Bartz; James L Januzzi; Daniel Levy; Laura M G Meems; Stephan J L Bakker; Joao A C Lima; Mary Cushman; Douglas S Lee; Thomas J Wang; Christopher R deFilippi; David M Herrington; Matthew Nayor; Ramachandran S Vasan; Julius M Gardin; Jorge R Kizer; Alain G Bertoni; Norrina B Allen; Ron T Gansevoort; Sanjiv J Shah; John S Gottdiener; Jennifer E Ho; Rudolf A de Boer
Journal:  J Am Coll Cardiol       Date:  2020-09-22       Impact factor: 24.094

4.  Clinical impact of cardiovascular disease on patients with bronchiectasis.

Authors:  Shanshan Chen; Aimin Qiu; Zhang Tao; Hailin Zhang
Journal:  BMC Pulm Med       Date:  2020-04-23       Impact factor: 3.317

5.  High level of D-dimer predicts ischemic stroke in patients with infective endocarditis.

Authors:  Nan Xu; Yakun Fu; Shuanglin Wang; Shenghui Li; Dong Cai
Journal:  J Clin Lab Anal       Date:  2020-02-03       Impact factor: 2.352

6.  Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Authors:  Neil A Zakai; Suzanne E Judd; Brett Kissela; George Howard; Monika M Safford; Mary Cushman
Journal:  Thromb Haemost       Date:  2018-06-11       Impact factor: 5.249

7.  D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.

Authors:  Laura M Raffield; Neil A Zakai; Qing Duan; Cecelia Laurie; Joshua D Smith; Marguerite R Irvin; Margaret F Doyle; Rakhi P Naik; Ci Song; Ani W Manichaikul; Yongmei Liu; Peter Durda; Jerome I Rotter; Nancy S Jenny; Stephen S Rich; James G Wilson; Andrew D Johnson; Adolfo Correa; Yun Li; Deborah A Nickerson; Kenneth Rice; Ethan M Lange; Mary Cushman; Leslie A Lange; Alex P Reiner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09-14       Impact factor: 8.311

8.  Elevated level of D-dimer increases the risk of stroke.

Authors:  Jing Zhang; Yanlin Song; Baoyin Shan; Min He; Qingqing Ren; Yunhui Zeng; Zhiyong Liu; Hao Liu; Jianguo Xu
Journal:  Oncotarget       Date:  2017-12-18

9.  D-dimer in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis.

Authors:  Guangxu Lu; Tong Li; Haoqi Ye; Shujin Liu; Peng Zhang; Wenliang Wang
Journal:  J Orthop Surg Res       Date:  2020-07-16       Impact factor: 2.359

10.  Interferon gamma-induced protein 10 (IP-10) and cardiovascular disease in African Americans.

Authors:  Colton Leavitt; Neil A Zakai; Paul Auer; Mary Cushman; Ethan M Lange; Emily B Levitan; Nels Olson; Timothy A Thornton; Russell P Tracy; James G Wilson; Leslie A Lange; Alex P Reiner; Laura M Raffield
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.